By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Business of development and commercialization of bio-aesthetic products425.86K100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States50.32K100.00%